Neil A. Fenske, MD

Dr. Neil Fenske is a dermatopathologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and professor and chairman of the Department of Dermatology and Cutaneous Surgery at the University of South Florida. Dr. Fenske’s research and clinical interests include skin cancer, melanoma, aging skin and psoriasis. A graduate of St. Louis University School of Medicine, Dr. Fenske completed a residency in dermatology and was chief resident at the University of Wisconsin Center for Health Sciences. Dr. Fenske has received numerous professional awards, including the AMA Physician’s Recognition Award, the American Academy of Dermatology CME Award, Best Doctors in America, America’s Top Doctors and America’s Top Cancer Doctors.  He has published extensively in professional journals, medical texts and other publications. Dr. Fenske has served the American Academy of Dermatology in numerous areas, including regional coordinator for the National Melanoma/Skin Cancer Screening Program. He also has held numerous offices, including vice president and president, of the Florida Society of Dermatologic Surgeons.  

Provider

Neil A. Fenske, MD

Dermatology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Cutaneous Oncology

Print Print Physician Bio

Education & Training

BOARD CERTIFICATION:
  • Dermatopathology
FELLOWSHIP:
  • St. Mary's Hospital -
RESIDENCY:
  • University of Wisconsin Center of Health Sciences - Dermatology
MEDICAL SCHOOL:
  • St. Louis University School of Medicine - MD
Provider

Neil A. Fenske, MD

Dermatology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Cutaneous Oncology

Print Print Physician Bio

Publications

  • Gheit T, Dutta S, Oliver J, Robitaille A, Hampras S, Combes JD, McKay-Chopin S, Le Calvez-Kelm F, Fenske N, Cherpelis B, Giuliano AR, Franceschi S, McKay J, Rollison DE, Tommasino M. Isolation and characterization of a novel putative human polyomavirus. Virology. 2017 Jun;506:45-54. Pubmedid: 28342387.
  • Hampras S, Pawlita M, Tommasino M, Park J, Burnette P, Fenske N, Cherpelis B, Rollison D. Telomere length, cutaneous beta human papillomavirus infection and cutaneous squamous cell carcinoma. Dermatol Online J. 2016 Sep;22(9). Pubmedid: 28329670.
  • Bennett AE, Fenske NA, Rodriguez-Waitkus P, Messina JL. IgG4-related skin disease may have distinct systemic manifestations: a systematic review. Int J Dermatol. 2016 Nov;55(11):1184-1195. Pubmedid: 27419384.
  • Hampras SS, Reed RA, Bezalel S, Cameron M, Cherpelis B, Fenske N, Sondak VK, Messina J, Tommasino M, Gheit T, Rollison DE. Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin. J Skin Cancer. 2016 Nov;2016:1368103. Pubmedid: 27891253. Pmcid: PMC5116506.
  • Hampras SS, Michel A, Schmitt M, Waterboer T, Kranz L, Gheit T, Fisher K, Sondak VK, Messina J, Fenske N, Cherpelis B, Tommasino M, Pawlita M, Rollison DE. Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma. Infect Agent Cancer. 2015 Oct;10:35. Pubmedid: 26483848. Pmcid: PMC4610041.
  • Hampras SS, Rollison DE, Tommasino M, Gheit T, Schabath MB, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Iannacone MR, Schmitt M, Pawlita M. Genetic variations in the epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human papillomavirus infection and squamous cell carcinoma of the skin. Br J Dermatol. 2015 Dec;173(6):1532-1535. Pubmedid: 26126409. Pmcid: PMC4695259.
  • Iannacone MR, Gheit T, Pfister H, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Silling S, Pawlita M, Tommasino M, Rollison DE. Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer. 2014 May;134(9):2231-2244. Pubmedid: 24136717. Pmcid: PMC4545525.
  • Iannacone MR, Wang W, Stockwell HG, O'Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Rollison DE. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer. 2013 May;12:417. Pubmedid: 22994655. Pmcid: PMC3517361.
  • Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Ferrer-Gil S, Michael KM, McKay-Chopin S, Pawlita M, Tommasino M, Rollison DE. Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol. 2013 Jun;133(6):1512-1520. Pubmedid: 23303448. Pmcid: PMC4545594.
  • Ross K, Cherpelis B, Lien M, Fenske N. Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion. Dermatol Surg. 2013 Dec;39(12):1733-1744. Pubmedid: 24118243.
  • Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 2013 Aug;37(4):434-439. Pubmedid: 23523330. Pmcid: PMC3679277.
  • Patel N, Stranahan D, Fenske NA. Unilateral telangiectasia macularis eruptiva perstans of the breast. Cutis. 2012 Jul;90(1):26-28. Pubmedid: 22908729.
  • Rollison DE, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Iannacone MR, Michael KM, Gheit T, Waterboer T, Tommasino M, Pawlita M. Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):74-81. Pubmedid: 22016472. Pmcid: PMC4543303.
  • Rollison DE, Iannacone MR, Messina JL, Glass LF, Giuliano AR, Roetzheim RG, Cherpelis BS, Fenske NA, Jonathan KA, Sondak VK. Case-control study of smoking and non-melanoma skin cancer. Cancer Causes Control. 2012 Feb;23(2):245-254. Pubmedid: 22101452.
  • Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Michael KM, Tommasino M, Pawlita M, Rollison DE. Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1303-1313. Pubmedid: 22707711. Pmcid: PMC4543310.
  • Iannacone MR, Wang W, Stockwell HG, O'Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Michael KM, Waterboer T, Pawlita M, Rollison DE. Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis. 2012 Aug;206(3):399-406. Pubmedid: 22661119. Pmcid: PMC4542577.
  • Thareja S, Paghdal K, Lien MH, Fenske NA. Reticular erythematous mucinosis - a review. Int J Dermatol. 2012 Aug;51(8):903-909. Pubmedid: 22788804.
  • Etzkorn JR, Pothiawala S, Fenske NA. Program Spotlight: The USF Department of Dermatology and Cutaneous Surgery Residency Training Program. J Drugs Dermatol. 2012 Apr;11(4):524-525. Pubmedid: 22453592.
  • Lien MH, Fenske NA, Glass LF. Advances in the Chemoprevention of Non-melanoma Skin Cancer in High-Risk Organ Transplant Recipients. Semin Oncol. 2012 Apr;39(2):134-138. Pubmedid: 22484184.
  • Marcum CB, Zager JS, Bélongie IP, Messina JL, Fenske NA. Profound proliferating angiolymphoid hyperplasia with eosinophilia of pregnancy mimicking angiosarcoma. Cutis. 2011 Sep;88(3):122-128. Pubmedid: 22017064.
  • Fenske NA, Spencer J, Adam F. Actinic keratoses: past, present and future. J Drugs Dermatol. 2010 May;9(5 Suppl ODAC Conf Pt 1):s45-s49. Pubmedid: 20518359.
  • Baldwin BT, Cherpelis BS, Sondak V, Fenske NA. Sentinel lymph node biopsy in melanoma: Facts and controversies. Clin Dermatol. 2010 May;28(3):319-323. Pubmedid: 20541686.
  • Liu SW, Lien MH, Fenske NA. The effects of alcohol and drug abuse on the skin. Clin Dermatol. 2010 Jul;28(4):391-399. Pubmedid: 20620755.
  • Pothiawala SZ, Baldwin BT, Cherpelis BS, Lien MH, Fenske NA. The role of phototherapy in cutaneous T-cell lymphoma. J Drugs Dermatol. 2010 Jul;9(7):764-772. Pubmedid: 20677530.
  • Pothiawala SZ, Baldwin BT, Cherpelis BS, Glass LF, Fenske NA. The role of maintenance phototherapy in cutaneous T-cell lymphoma. J Drugs Dermatol. 2010 Jul;9(7):800-803. Pubmedid: 20677536.
  • Baldwin BT, Cherpelis BS, Fenske NA. Discussing sentinel lymph node biopsy with your melanoma patients. J Drugs Dermatol. 2010 Jul;9(7):790-792. Pubmedid: 20677534.
  • Lien MH, Baldwin BT, Thareja SK, Fenske NA. Merkel cell carcinoma: clinical characteristics, markers, staging and treatment. J Drugs Dermatol. 2010 Jul;9(7):779-784. Pubmedid: 20677532.
  • Vasher M, Smithberger E, Lien MH, Fenske NA. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J Drugs Dermatol. 2010 Jul;9(7):844-850. Pubmedid: 20677542.
  • Cherpelis BS, Glass LF, Ladd S, Fenske NA. Mohs surgery for melanoma in situ: how we do it. J Drugs Dermatol. 2010 Jul;9(7):786-788. Pubmedid: 20677533.
  • Bickle K, Smithberger E, Lien MH, Fenske NA. Unilateral lichen planus pigmentosus mimicking acral lentiginous melanoma. J Drugs Dermatol. 2010 Jul;9(7):841-843. Pubmedid: 20677541.
  • Stranahan DR, Cherpelis BS, Fenske NA, Glass LF. Advances in immunostains used in Mohs surgery. J Drugs Dermatol. 2010 Jul;9(7):760-763. Pubmedid: 20677529.
  • Raziano RM, Clark GS, Cherpelis BS, Sondak VK, Cruse CW, Fenske NA, Glass LF. Staged margin control techniques for surgical excision of lentigo maligna. G Ital Dermatol Venereol. 2009 Jun;144(3):259-270. Pubmedid: 19528907.
  • Cherpelis BS, Turner L, Ladd S, Glass LF, Fenske NA. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery. Dermatol Surg. 2009 Jul;35(7):1050-1056. Pubmedid: 19469800.
  • Stranahan D, Cherpelis BS, Glass LF, Ladd S, Fenske NA. Immunohistochemical stains in Mohs surgery: a review. Dermatol Surg. 2009 Jul;35(7):1023-1034. Pubmedid: 19397647.
  • Saltzberg F, Barron G, Fenske N. Deforming self-treatment with herbal "black salve". Dermatol Surg. 2009 Jul;35(7):1152-1154. Pubmedid: 19438678.
  • Marquez CB, Smithberger EE, Bair SM, Wenham RM, Fenske NA, Glass LF, Cherpelis BS. Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene. Cancer Control. 2009 Jan;16(1):66-69. Pubmedid: 19078932.
  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA. Topical corticosteroids in dermatology. J Drugs Dermatol. 2009 Dec;8(12):1093-1105. Pubmedid: 20027937.
  • Rollison D, Pawlita M, Giuliano A, Iannacone M, Sondak V, Messina J, Cruse C, Fenske N, Glass L, Kienstra M, Michael K, Waterboer T, Gheit T, Tommasino M. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer. 2008 Nov;123(10):2337-2342. Pubmedid: 18729188.
  • Patrick R, Fenske N, Messina J. Primary mucosal melanoma. J Am Acad Dermatol. 2007 May;56(5):828-834. Pubmedid: 17349716.
  • Shistik G, Prakash A, Fenske N, Glass L. Treatment of locally metastatic melanoma: a novel approach. J Drugs Dermatol. 2007 Aug;6(8):830-832. Pubmedid: 17763615.
  • Keehn C, Belongie I, Shistik G, Fenske N, Glass L. The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control. 2007 Apr;14(2):102-111. Pubmedid: 17387295.
  • Baldwin B, Prakash A, Fenske N, Messina J. Aquagenic syringeal acrokeratoderma: report of a case with histologic findings. J Am Acad Dermatol. 2006 May;54(5):899-902. Pubmedid: 16635679.
  • Lober B, Fenske N. Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol. 2004 5(6;5(6):395-401. Pubmedid: 15663336.
  • Bickle K, Glass L, Messina J, Fenske N, Siegrist K. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg. 2004;23(1):46-53. Pubmedid: 15095915.
  • Perrott R, Glass L, Reintgen D, Fenske N. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol. 2003 Oct;49(4):567-588. Pubmedid: 14512901.
  • Reschly M, Messina J, Zaulyanov L, Cruse W, Fenske N. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29(2):135-140. Pubmedid: 12562341.
  • Fairbee S, Fenske N, Messina J, Hogan D, Castellano-Howard L. Extrafacial granuloma faciale: report of a case and response to treatment. Cutis. 2001 May;67(5):413-415. Pubmedid: 11381859.
  • Rinker MH, Fenske NA, Scalf LA, Glass LF. Histologic variants of squamous cell carcinoma of the skin. Cancer Control. 2001 Jul;8(4):354-363. Pubmedid: 11483889.
  • McMasters K, Reintgen D, Ross M, Gershenwald J, Edwards M, Sober A, Fenske N, Glass L, Balch C. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol. 2001;19(11):2851-2855. Pubmedid: 11387357.
  • Cherpelis B, Haddad F, Messina J, Cantor A, Fitzmorris K, Reintgen D, Fenske N, Glass L. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol. 2001;44(5):762-766. Pubmedid: 11312421.
  • Cherpelis B, Fenske N. Purpuric irritant contact dermatitis induced by Agave americana. Cutis. 2000 Oct;66(4):287-288. Pubmedid: 11109152.
  • Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000;7(1):72-83. Pubmedid: 10740663.
  • Smith K, Fenske N. Cutaneous manifestation of alcohol abuse. J Am Acad Derm. 2000;43(1):1-16. Pubmedid: 10863217.
  • Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol. 1999 Jun;6(4):345-349. Pubmedid: 10379854.
  • Lipp KE, Shenefelt PD, Nelson RP, Fenske N. Persistent Sweet's syndrome occurring in a child with a primary immunodeficiency. J Am Acad Dermatol. 1999;40(5):838-841. Pubmedid: 10321630.
  • Shivers S, Wang X, Li W, Joseph E, Messina J, Glass L, DeConti R, Cruse W, Berman C, Fenske N, Lyman G, Reintgen D. Molecular staging of malignant melanoma: correlation with clinical outcome. Jama. 1998 Oct;280(16):1410-1415. Pubmedid: 9801000.
  • Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998 Mar;5(2):119-125. Pubmedid: 9527264.
  • Harvey D, Fenske N, Glass L. Rosaceous lymphedema: a rare variant of a common disorder. Cutis. 1998 Jun;61(6):321-324. Pubmedid: 9640553.
  • Glass L, Cottam J, Reintgen D, Fenske N. Lymphatic mapping and sentinel node biopsy: state of the art in the management of high risk melanoma. J Am Acad Derm. 1998;39(4):603-610. Pubmedid: 9777768.
  • Glass L, Keller K, Messina J, Dalton J, Yag-Howard C, Fenske N. Cutaneous T-cell lymphoma. Cancer Control. 1998;5(1):11-11. Pubmedid: 10761012.
  • Lipp K, Shenefelt P, Fenske N. The immunologic bullous diseases: diagnosis and management. Geriatrics. 1998;53(12):43-53. Pubmedid: 9861898.
  • Keller K, Fenske N. Uses of vitamins A,C,E and related compounds in dermatology: a review. J Am Acad Dermatol. 1998;39(4):611-625. Pubmedid: 9777769.
  • Fenske N. How to discuss photodamage with your patients. Skin And Aging. 1998;44-50.
  • Keller KL, Fenske NA, Glass LF. Cancer of the skin in the older patient. Clin Geriatr Med. 1997 May;13(2):339-361. Pubmedid: 9115455.
  • Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997 Mar;84(3):182-187. Pubmedid: 9143170.
  • Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse C, Rapaport D, Berman C, Glass L, Fenske N, Einstein, Jr. A, Lyman G. Investment in new technology research can save future health care dollars. J Fla Med Assoc. 1997;84(3):175-181. Pubmedid: 9143169.
  • Kamath D, Cantor A, Glass L, Fenske N, Cruse C, Wells K, Rapaport D, DeConti R, Messina J, Reintgen D. Florida's undeclared epidemic: malignant melanoma. J Fla Med Assoc. 1997;84(3):161-165. Pubmedid: 9143167.
  • Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs. Ann Surg Oncol. 1997;4:19-23. Pubmedid: 8985513.
  • Le A, Fenske N. An unusual granulomatous disease in the elderly. Arch Dermatol. 1997;133(10):1303-1303. Pubmedid: 9382571.
  • Le A, Fenske N, Glass L, Messina J. Malignant melanoma: differential diagnosis of pigmented lesions. J Fla Med Assoc. 1997;84(3):166-174. Pubmedid: 9143168.
  • Smith J, Smith S, Fenske N. More trouble for smokers - skin cancers and wrinkles. Skin Cancer Foundation Journal. 1997;15:18-19. Pubmedid: noPMID.
  • Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic mapping for melanoma: long-term results of regional nodal sampling with radioguided surgery. Cancer Control. 1997;4:483-490. Pubmedid: 10763056.
  • Milotes G, Lyman G, Cruse C, Puleo C, Albertini J, Rapaport D, Glass L, Fenske N, Soriano T, Cuny C, VanVoorhis N, Reintgen D. Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol. 1996 Nov;3(6):558-563. Pubmedid: 8915488.
  • Vesper J, Fenske N. Hair darkening and new growth associated with etretinate therapy. J Am Acad Dermatol. 1996 May;34(5 Pt 1):860. Pubmedid: 8632091.
  • Heller R, Jaroszeski M, Glass L, Messina J, Rapaport D, DeConti R, Fenske N, Gilbert R, Mir L, Reintgen D. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996 Mar;77(5):964-971. Pubmedid: 8608491 .
  • Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996 Feb;223(2):217-224. Pubmedid: 8597518. Pmcid: PMC1235100.
  • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996 Aug;22(8):715-720. Pubmedid: 8780765.
  • Nixon D, Greene J, Sandin R, Fenske N, Glass L. Empirical treatment of subcutaneous phaeohyphomycosis with itraconazole. Infect Med. 1996;13(6):481-481.
  • Pepine M, Calderone D, Fenske N. The therapeutic role of topical tretinion in photoaging. J Geriatr Dermatol. 1996;4(5):156-168.
  • Nixon D, Greene J, Sandin R, Fenske N, Glass L. Empirical treatment of subcutaneous phaeohyphomycosis with itraconazole. Infect Med. 1996;13(6):481+-481+.
  • Nicol H, Fenske N. Photodamage: cause, clinical manifestations, and prevention. Plast Surg Nursing. 1996;16(1):9-21.
  • Glass L, Pepine M, Fenske N, Jaroszeski M, Reintgen D, Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol. 1996;132:1353-1357. Pubmedid: 8915314.
  • Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastasis. Am Surg. 1996;62:81-88. Pubmedid: 8540654.
  • Esperanza L, Fenske N. Hyperandrogenism, insulin resistance, and acathosis nigricans (HAIR-AN) syndrome: spontaneous remission in a 15-year-old girl. J Am Acad Dermatol. 1996;34(5):892-897. Pubmedid: 8621823.
  • Heller R, Jaroszeski M, Glass L, Messina J, Rapaport D, DeConti R, Fenske N, Gilbert R, Mir L, Reintgen D. Phase I/II trial of cutaneous and subcutaneous malignancies using electrochemotherapy. Cancer. 1996;75(5):964-971. Pubmedid: 8608491.
  • Glass L, Albertini J, Fenske N, Reintgen D. Lymphatic mapping and selective lymphadenectomy in patients with cutaneous melanoma. Curr Opin Hematol. 1996;3:63-70.
  • Smith J, Fenske N. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol. 1996;34(5):717-732. Pubmedid: 8632065.
  • Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996;21:979-983.
  • Messina J, Yag-Howard C, Fenske N. Cutaneous hyperpigmentation due to quinine gluconate. J Geriatr Dermatol. 1996;4(6):198-201.
  • Glass LF, DeGregoria L, Fenske NA, Jaroszeski M, Perrott R, Harvey DT, Reintgen DS, Heller R. Blemycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol. 1996;34(1):82-86. Pubmedid: 8543699.
  • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg. 1995 Nov;21(11):979-983. Pubmedid: 7582838.
  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986.
  • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986 .
  • Chaney J, Guffey, Stevens G, Schroer K, Fenske N, Reintgen D, Glass L. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen. J Cutan Pathol. 1995 Apr;22(2):122-127. Pubmedid: 7560343.
  • Haag M, Glass L, Fenske N. Merkel cell carcinoma: diagnosis and treatment. J Dermatol Surg. 1995;21:669-683. Pubmedid: 7633811.
  • Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995;4:183-197. Pubmedid: noPMID.
  • Smith J, Hogan D, Glass L, Fenske N. Multiple collagenomas in a patient with Down's syndrome. J Am Acad Derm. 1995;33:835-837. Pubmedid: 7593790.
  • Smith J, Fenske N. Herpes Zoster and internal malignancy. South Med J. 1995;88:1089-1092. Pubmedid: 7481976.
  • Harvey D, Fenske N. The razor blade biopsy technique; introduction of the adaptor designed shave biopsy instrument. Dermatol Surg. 1995;21:345-347. Pubmedid: 7728489.
  • Calderone D, Fenske N. The clinical spectrum of actinic elastosis. J Am Acad Dermatol. 1995;32:1016-1024. Pubmedid: 7751446.
  • Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate nodal staging of malignant melanoma. Cancer Control. 1995;2(5):405-414. Pubmedid: 10862181.
  • DeGregorie R, Fenske N, Glass L. Granulomatous slack skin: a possible precursor of Hodgkin's disease. J Am Acad Derm. 1995;33:1044-1047. Pubmedid: 7490351.
  • Vesper J, Messina J, Glass L, Fenske N. Profound proliferating pearly penile papules. Int J Dermatol. 1995;34:425-426. Pubmedid: 7657443.
  • Albers SE, Glass LF, Fenske NA. Lichen planus subtropicus: direct immunofluorescence findings and therapeutic response to hydroxychloroquine. Int J Dermatol. 1994 Sep;33(9):645-647. Pubmedid: 8002164.
  • Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G. The orderly progression of melanoma nodal metastases. Ann Surg. 1994 Dec;220(6):759-767. Pubmedid: 7986143. Pmcid: PMC1234478.
  • Albers S, Fenske N, Glass L, Brozena S, Szakacs J. Atypical B(2)-microglobulin amyloidosis following short-term hemodialysis. Am J Dermatopathol. 1994;16:179-184.
  • Fenske N, Koo J. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J Natl Med Assoc. 1994;86(18):1425-1426.
  • Wells K, Cruse C, Baker J, Daniels S, Stern R, Newman C, Seleznick M, Vasey F, Brozena S, Albers S, Fenske N. The health status of women following cosmetic surgery. Plast Reconstr Surg. 1994;93:907-912.
  • Poole S, Fenske N. Cutaneous markers of internal malignancy. J Am Acad Dermatol. 1994;30:675-675.
  • Reintgen D, Cruse C, Wells K, Berman C, Fenske N, Glass L, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler H, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220(6):759-767.
  • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;220:768-774.
  • Calderone D, Glass L, Seleznick M, Fenske N. Eccrine angiomatous hamartoma. J Dermatol Surg Oncol. 1994;20:837-838.
  • Poole S, Fenske N. Conceptual differences on the occurrence of internal malignancies in the FAMMM syndrome. J Am Acad Derm. 1994;30:674-674.
  • Shenefelt PD, Castellano LM, Fenske NA. Successful treatment of albopapuloid epidermolysis bullosa (Pasini's variant) with pulse topical corticosteroid therapy. J Am Acad Dermatol. 1993 Nov;29(5 Pt 1):785-786. Pubmedid: 8227555.
  • Brozena SJ, Fenske NA, Perez IR. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin Surg Oncol. 1993 May;9(3):165-167. Pubmedid: 8516598.
  • Lynn A, Brozena SJ, Espinoza CG, Fenske NA. Nevus of Ota acquisita of late onset. Cutis. 1993 Mar;51(3):194-196. Pubmedid: 8444053.
  • Albers SE, Brozena SJ, Fenske NA. A case of kwashiorkor. Cutis. 1993 Jun;51(6):445-446. Pubmedid: 8519189.
  • Albers S, Fenske N, Glass L. Erythema gyratum repens: direct immunofluorenscence microscopic findings. J Am Acad Derm. 1993;29:493-494.
  • Haag M, Brozena S, Fenske N. Attack of the scabies: what to do when an outbreak occurs. Geriatrics. 1993;48:45-53.
  • Poole S, Fenske N. Cutaneous markers of internal malignancy, part II: malignant involvement of the skin & the paraneoplastic dermatoses and environmental carcinogens. J Am Acad Derm. 1993;28:147-164.
  • Brozena S, Fenske N, Perez I. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin Surg Oncol. 1993;9:165-167.
  • Albers S, Brozena S, Fenske N. A case of Kwashiorkor. Cutis. 1993;51:445-446.
  • Poole S, Fenske N. Cutaneous markers of internal malignancy. J Am Acad Dermatol. 1993;29:800-801.
  • Fenske N, Vasey F. Silicone-associated connective-tissue disease: the debate rages. Arch Dermatol. 1993;129:97-98.
  • Lynn A, Brozena S, Espinoza C, Fenske N. Nevus of ota acquista of late onset. Cutis. 1993;51:194-196.
  • Shenefelt P, Castellano L, Fenske N. Successful treatment of albopapuloid epidermolysis bullosa (Pasini's variant) with pulse topical corticosteroid therapy. J Am Acad Derm. 1993;29:785-786.
  • Harvey D, Fenske N. Intrinsic aging and its role in nonmelanoma skin cancer formation. J Geriatr Dermatol. 1993;1:121-129.
  • Perez I, Fenske N, Brozena S. Malignant melanoma: differential diagnosis of the pigmented lesion. Semin Surg Oncol. 1993;9:168-173.
  • Nicol N, Fenske N. Photodamage: cause, clinical manifestations, and prevention. Derm Nurs. 1993;5:263-275.
  • Poole S, Fenske N. Cutaneous markers of internal malignancy, part I: malignant involvement of the skin & the genodermatoses. J Am Acad Dermatol. 1993;28:1-14.
  • Albers S, Brozena S, Glass L, Fenske N. Alkaptonuria and ochronosis: case report and review. J Am Acad Derm. 1992;27:609-614.
  • Kowalski D, Fenske N. The focal facial dermal dysplasias: report of a kindred and a proposed new classification. J Am Acad Derm. 1992;27:575-582.
  • Luria L, Proper S, Burnett S, Williams Jr. C, Fenske N. An anatomical basis for prognosis of malignant melanoma. Plast Reconstr Surg. 1992;90(2):263-269.
  • Reintgen D, Cruse C, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass L, Alvarez L, Brozena S, Fenske N, Fabri P. The effectiveness of skin cancer screening and continuing education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992;1:379-384.
  • Morgan MB, Kouseff BG, Silver A, Shenefelt PC, Fenske NA, Espinoza CG. Eruptive vellus hair cysts and neurologic abnormalities: two related conditions?. Cutis. 1991 Jun;47(6):413-415. Pubmedid: 1879179.
  • Cohen LE, Faske I, Fenske NA, Greist MA. Prostaglandin infusion therapy for intermittent digital ischemia in a patient with mixed connective tissue disease. Case report and review of the literature. J Am Acad Dermatol. 1989 May;20(5 Pt 2):893-897. Pubmedid: 2654223.
  • Waterman G, Epstein JD, Fenske NA. Herpes zoster infection with trigeminal and facial nerve involvement. Cutis. 1989 Mar;43(3):262-263. Pubmedid: 2707055.
  • Milam CP, Cohen LE, Fenske NA, Ling NS. Scleromyxedema: therapeutic response to isotretinoin in three patients. J Am Acad Dermatol. 1988 Sep;19(3):469-477. Pubmedid: 3170809.
  • Proper SA, Fenske NA, Burnett SM, Luria LW. Compromised wound repair caused by perioperative use of ibuprofen. J Am Acad Dermatol. 1988 May;18(5 Pt 2):1173-1179. Pubmedid: 3372780.
  • Spencer SA, Fenske NA, Espinoza CG, Hamill JR, Cohen LE, Espinoza LR. Granuloma annulare-like eruption due to chronic Epstein-Barr virus infection. Arch Dermatol. 1988 Feb;124(2):250-255. Pubmedid: 2829748.
  • Brozena SJ, Cohen LE, Fenske NA. Folliculitis decalvans--response to rifampin. Cutis. 1988 Dec;42(6):512-515. Pubmedid: 3229140.
  • Lober CW, Fenske NA. Suture materials for closing the skin and subcutaneous tissues. Aesthetic Plast Surg. 1986;10(4):245-248. Pubmedid: 3544739.
  • Madjar DD, Carvallo E, Proper SA, Fenske NA. Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection. J Dermatol Surg Oncol. 1985 Jul;11(7):708-712. Pubmedid: 4008739.
  • Spencer SA, Fenske NA, Bookbinder SA, Vasey FB. Diflorasone diacetate ointment 0.05 percent in conjunction with UVB and tar in a modified outpatient Goeckerman regimen. Cutis. 1985 Aug;36(2):169-172. Pubmedid: 4028832.
  • Fenske NA, Waisman M, Espinoza CG. Bowen's disease of the palm. Cutis. 1983 Jun;31(6):673-677. Pubmedid: 6861519.
  • Fenske NA, Barker S, Vasey FB. Cutaneous erythematous reaction patterns. Am Fam Physician. 1983 Aug;28(2):99-106. Pubmedid: 6881013.
  • Fenske NA, Gern JE, Pierce D, Vasey FB. Vesiculopustular eruption of ulcerative colitis. Arch Dermatol. 1983 Aug;119(8):664-669. Pubmedid: 6135392.
  • Lober CW, Mendelsohn HE, Datnow B, Fenske NA. Clinical and histologic features of orf. Cutis. 1983 Aug;32(2):142-4, 146. Pubmedid: 6617252.
  • Flowers FP, Slazinski L, Fenske NA, Pullara TJ. Topical squaric acid dibutylester therapy for alopecia areata. Cutis. 1982 Dec;30(6):733-736. Pubmedid: 6756800.
  • Fenske NA, Millns JL. Resistant cutaneous infection caused by Mycobacterium chelonei. Arch Dermatol. 1981 Mar;117(3):151-153. Pubmedid: 7212728.
  • Flowers FP, Fenske NA, Whisman PA. Agent Orange: what's it all about?. J Fla Med Assoc. 1981 Dec;68(12):991-992. Pubmedid: 7328402.
  • Fenske NA, Millns JL. Cutaneous pigmentation due to minocycline hydrochloride. J Am Acad Dermatol. 1980 Sep;3(3):308-310. Pubmedid: 6450227.
  • Fenske NA, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. Jama. 1980 Sep;244(10):1103-1106. Pubmedid: 6447805.
  • Fenske NA, Johnson SA. Major causes of alopecia with suggestions for history taking, workup, and therapy. Postgrad Med. 1976 Sep;60(3):79-85. Pubmedid: 959086.
  • Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 4(5):389-395. Pubmedid: 9259965.
  • Bookbinder SA, Espinoza LR, Fenske NA, Germain BF, Vasey FB. Methotrexate: its use in the rheumatic diseases. Clin Exp Rheumatol. 2(2):185-193. Pubmedid: 6398173.
  • Shistik G, Scalf L, Fenske N, Glass L. Follicular mycosis fungoides: successful treatment with oral bexarotene. J Drugs Dermatol. 3(3):301-304. Pubmedid: 15176165.

Provider

Neil A. Fenske, MD

Dermatology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Cutaneous Oncology

Print Print Physician Bio

Participating Trials

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).


Provider

Neil A. Fenske, MD

Dermatology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Cutaneous Oncology

Print Print Physician Bio